Icosavax Stock Target Price
ICVXDelisted Stock | USD 9.02 0.12 1.31% |
Icosavax fundamentals help investors to digest information that contributes to Icosavax's financial success or failures. It also enables traders to predict the movement of Icosavax Stock. The fundamental analysis module provides a way to measure Icosavax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icosavax stock.
Icosavax |
Icosavax Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icosavax's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics of similar companies.Icosavax is currently under evaluation in target price category among its peers.
Icosavax Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.27 | |||
Current Valuation | 547.9 M | |||
Shares Outstanding | 50.23 M | |||
Shares Owned By Insiders | 3.47 % | |||
Shares Owned By Institutions | 87.64 % | |||
Number Of Shares Shorted | 321.31 K | |||
Price To Earning | 63.56 X | |||
Price To Book | 3.31 X | |||
Price To Sales | 153.31 X | |||
Gross Profit | (30.97 M) | |||
EBITDA | (103.19 M) | |||
Net Income | (96.71 M) | |||
Cash And Equivalents | 242.8 M | |||
Cash Per Share | 6.09 X | |||
Total Debt | 8.79 M | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 20.89 X | |||
Book Value Per Share | 4.64 X | |||
Cash Flow From Operations | (71.48 M) | |||
Short Ratio | 0.34 X | |||
Earnings Per Share | (2.20) X | |||
Target Price | 18.5 | |||
Number Of Employees | 60 | |||
Beta | 1.28 | |||
Market Capitalization | 769.04 M | |||
Total Asset | 238.68 M | |||
Retained Earnings | (185.83 M) | |||
Working Capital | 210.12 M | |||
Z Score | 51.0 | |||
Net Asset | 238.68 M |
About Icosavax Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Icosavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icosavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icosavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Transaction History View history of all your transactions and understand their impact on performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |